Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Seagen Inc.
  6. News
  7. Summary
    SGEN   US81181C1045

SEAGEN INC.

(SGEN)
  Report
Real-time Estimate Cboe BZX  -  01:16 2022-10-04 pm EDT
138.90 USD   +0.87%
09/28Seagen and Zai Lab Announce Regional Strategic Collaboration and License Agreement for TIVDAK
AQ
09/28Seagen and Zai Lab Announce Regional Strategic Collaboration and License Agreement for TIVDAK (tisotumab vedotin-tftv)
AQ
09/28Zai Lab Strikes Licensing Deal with Nasdaq-listed Seagen for Cervical Cancer Drug
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

SEAGEN INC. : Other Events, Financial Statements and Exhibits (form 8-K)

08/12/2022 | 03:09pm EDT

Item 8.01 Other Events

On August 12, 2022, Seagen Inc. issued a press release regarding the outcome of the arbitration with Daiichi Sankyo Co. Ltd. relating to the parties' 2008 collaboration agreement for the use of Seagen's antibody-drug conjugate technology. The press release is attached as Exhibit 99.1 to this current report and is incorporated by reference herein.

Item 9.01 Financial Statements and Exhibits

(d) Exhibits

99.1     Press Release of Seagen Inc. dated August 12, 2022

104    Cover Page Interactive Data File (formatted in Inline XBRL)



--------------------------------------------------------------------------------

© Edgar Online, source Glimpses

All news about SEAGEN INC.
09/28Seagen and Zai Lab Announce Regional Strategic Collaboration and License Agreement for ..
AQ
09/28Seagen and Zai Lab Announce Regional Strategic Collaboration and License Agreement for ..
AQ
09/28Zai Lab Strikes Licensing Deal with Nasdaq-listed Seagen for Cervical Cancer Drug
MT
09/27Zai Lab Signs Exclusive Collaboration, License Agreement With Seagen to Develop, Commer..
MT
09/27Seagen and Zai Lab Announce Regional Strategic Collaboration and License Agreement for ..
BU
09/27Seagen and Zai Lab Announce Regional Strategic Collaboration and License Agreement for ..
CI
09/26Sector Update: Health Care Stocks Fall on Monday
MT
09/26Sector Update: Health Care
MT
09/26Top Midday Gainers
MT
09/26Seagen, Lava Therapeutics Sign License Agreement for Pre-Clinical Asset Targeting Solid..
MT
More news
Analyst Recommendations on SEAGEN INC.
More recommendations